China SXT Pharmaceuticals Inc (SXTC) — Capital Reinvestment Ratio
China SXT Pharmaceuticals Inc (SXTC) has a Capital Reinvestment Ratio of 0.11x as of December 2022, meaning it reinvests 0% of its operating cash flow ($234.18K) in capital expenditures ($25.28K). See SXTC net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China SXT Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2022)
This chart tracks China SXT Pharmaceuticals Inc's Capital Reinvestment Ratio across 6 annual periods. Check China SXT Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc (2016–2022)
Year-by-year Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc from 2016 to 2022. For live market cap and broader valuation context, see how much is China SXT Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.23x | $268.29K | $62.49K | ▼ -46.5% |
| 2020 | 0.44x | $934.25K | $406.66K | ▼ -82.9% |
| 2019 | 2.55x | $239.19K | $610.09K | ▲ +366.1% |
| 2018 | 0.55x | $1.92 Million | $1.05 Million | ▼ -13.9% |
| 2017 | 0.64x | $293.04K | $186.31K | ▲ +19.6% |
| 2016 | 0.53x | $182.47K | $96.99K | — |